Filing Details
- Accession Number:
- 0001628280-25-016741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-04 13:36:44
- Reporting Period:
- 2025-03-03
- Filing Date:
- 2025-04-04
- Accepted Time:
- 2025-04-04 13:36:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 1600 West End Ave., Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-03 | 47 | $5.54 | 282,890 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-04 | 47 | $5.11 | 282,937 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-05 | 47 | $6.75 | 282,984 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-06 | 47 | $6.57 | 283,031 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-07 | 47 | $6.51 | 283,078 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-10 | 37 | $5.85 | 283,115 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-11 | 37 | $4.85 | 283,152 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-12 | 37 | $5.17 | 283,189 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-13 | 37 | $5.47 | 283,226 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-14 | 37 | $5.38 | 283,263 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-17 | 37 | $5.41 | 283,300 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-18 | 37 | $5.12 | 283,337 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-19 | 37 | $5.41 | 283,374 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-20 | 37 | $5.07 | 283,411 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-21 | 37 | $4.89 | 283,448 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-24 | 45 | $4.42 | 283,493 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-25 | 45 | $4.45 | 283,538 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-26 | 45 | $4.41 | 283,583 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-27 | 45 | $4.20 | 283,628 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-28 | 45 | $4.20 | 283,673 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-31 | 45 | $4.29 | 283,718 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
Billionaire Hedge Funds
